Biocon shares zoom 4% as Jefferies upgrades to "hold" amid positive news inflow, sets Rs 400 target




Biocon shares surged 4.4% to an intraday high of ₹374.55 on the BSE today, after foreign brokerage firm Jefferies upgraded the stock’s rating from "Underperform" to "Hold" and raised its target price to ₹400 from the previous ₹280.

Comments